| 101 |
29936228 | Identification of COX-2 inhibitors via structure-based virtual screening and molecular dynamics simulation. | 2018 Aug |
2 |
| 102 |
29974839 | Cytotoxic effect of 2, 5-dimethyl-celecoxib as a structural analog of celecoxib on human colorectal cancer (HT-29) cell line. | 2018 May 30 |
3 |
| 103 |
30038488 | Radiosensitivity enhancement by combined treatment of nimotuzumab and celecoxib on nasopharyngeal carcinoma cells. | 2018 |
1 |
| 104 |
30038944 | The impact of celecoxib on outcomes in advanced prostate cancer patients undergoing androgen deprivation therapy. | 2018 |
1 |
| 105 |
30083389 | Using quantitative systems pharmacology to evaluate the drug efficacy of COX-2 and 5-LOX inhibitors in therapeutic situations. | 2018 |
1 |
| 106 |
30106307 | Rational Druggability Investigation Toward Selection of Lead Molecules: Impact of the Commonly Used Spices on Inflammatory Diseases. | 2018 Oct |
1 |
| 107 |
30131758 | Protective Effect of Celecoxib on Early Postoperative Cognitive Dysfunction in Geriatric Patients. | 2018 |
1 |
| 108 |
30216848 | Structural alterations based on naproxen scaffold: Synthesis, evaluation of antitumor activity and COX-2 inhibition, and molecular docking. | 2018 Oct 5 |
2 |
| 109 |
30288088 | Nonsteroidal anti-inflammatory drugs in chronic pain: implications of new data for clinical practice. | 2018 |
1 |
| 110 |
30349293 | Complete response associated with lenalidomide and celecoxib in a case of primary refractory Hodgkin lymphoma. | 2018 |
3 |
| 111 |
30570856 | Research on the inhibiting effect of tanshinone IIA on colon cancer cell growth via COX-2-Wnt/β-catenin signaling pathway. | 2018 Sep-Oct |
2 |
| 112 |
26982261 | Deciphering the mechanism behind the varied binding activities of COXIBs through Molecular Dynamic Simulations, MM-PBSA binding energy calculations and per-residue energy decomposition studies. | 2017 Mar |
1 |
| 113 |
27569276 | Risk of perioperative bleeding related to highly selective cyclooxygenase-2 inhibitors: A systematic review and meta-analysis. | 2017 Feb |
1 |
| 114 |
27666139 | Celecoxib enhances the inhibitory effect of 5-FU on human squamous cell carcinoma proliferation by ROS production. | 2017 Apr |
1 |
| 115 |
27761963 | Celecoxib and 2,5-dimethylcelecoxib inhibit intestinal cancer growth by suppressing the Wnt/β-catenin signaling pathway. | 2017 Jan |
1 |
| 116 |
27769779 | Synergistic inhibitory effects of Celecoxib and Plumbagin on melanoma tumor growth. | 2017 Jan 28 |
2 |
| 117 |
27837994 | Synthesis, biological evaluation, docking study and ulcerogenicity profiling of some novel quinoline-2-carboxamides as dual COXs/LOX inhibitors endowed with anti-inflammatory activity. | 2017 Feb 15 |
1 |
| 118 |
27864660 | Effects of CYP2C9 genetic polymorphisms on the pharmacokinetics of celecoxib and its carboxylic acid metabolite. | 2017 Mar |
1 |
| 119 |
28007462 | Celecoxib inhibits osteoblast maturation by suppressing the expression of Wnt target genes. | 2017 Jan |
1 |
| 120 |
28053596 | Celecoxib enhances anticancer effect of cisplatin and induces anoikis in osteosarcoma via PI3K/Akt pathway. | 2017 |
1 |
| 121 |
28057325 | Design, synthesis and biological screening of some novel celecoxib and etoricoxib analogs with promising COX-2 selectivity, anti-inflammatory activity and gastric safety profile. | 2017 Feb |
1 |
| 122 |
28119811 | 2,3-Diaryl-3H-imidazo[4,5-b]pyridine derivatives as potential anticancer and anti-inflammatory agents. | 2017 Jan |
1 |
| 123 |
28126288 | Medicinal attributes of 1,2,3-triazoles: Current developments. | 2017 Apr |
1 |
| 124 |
28212885 | Epinephrine promotes COX-2-dependent immune suppression in myeloid cells and cancer tissues. | 2017 May |
4 |
| 125 |
28231855 | COX-2 expression positively correlates with PD-L1 expression in human melanoma cells. | 2017 Feb 23 |
2 |
| 126 |
28283800 | Blocking COX-2 induces apoptosis and inhibits cell proliferation via the Akt/survivin- and Akt/ID3 pathway in low-grade-glioma. | 2017 Apr |
1 |
| 127 |
28285845 | A stratified randomized double-blind phase II trial of celecoxib for treating patients with cervical intraepithelial neoplasia: The potential predictive value of VEGF serum levels: An NRG Oncology/Gynecologic Oncology Group study. | 2017 May |
1 |
| 128 |
28368394 | Inhibition of cyclooxygenase-2-mediated matriptase activation contributes to the suppression of prostate cancer cell motility and metastasis. | 2017 Aug 10 |
1 |
| 129 |
28386348 | Inhibition of COX-2/PGE2 cascade ameliorates cisplatin-induced mesangial cell apoptosis. | 2017 |
2 |
| 130 |
28418202 | Benzodioxole-Pyrazole Hybrids as Anti-Inflammatory and Analgesic Agents with COX-1,2/5-LOX Inhibition and Antioxidant Potential. | 2017 May |
1 |
| 131 |
28423516 | The addition of celecoxib improves the antitumor effect of cetuximab in colorectal cancer: role of EGFR-RAS-FOXM1-β- catenin signaling axis. | 2017 Mar 28 |
1 |
| 132 |
28450158 | The ErbB family and androgen receptor signaling are targets of Celecoxib in prostate cancer. | 2017 Aug 1 |
1 |
| 133 |
28500957 | Design & synthesis of novel oxazolone & triazinone derivatives and their biological evaluation as COX-2 inhibitors. | 2017 Jun |
1 |
| 134 |
28528242 | Efficacy and safety of celecoxib monotherapy for mild to moderate depression in patients with colorectal cancer: A randomized double-blind, placebo controlled trial. | 2017 Sep |
1 |
| 135 |
28536229 | Cyclooxygenase-2 inhibitor-induced acute interstitial nephritis. | 2017 May 22 |
1 |
| 136 |
28591155 | Electroacupuncture prevents endothelial dysfunction induced by ischemia-reperfusion injury via a cyclooxygenase-2-dependent mechanism: A randomized controlled crossover trial. | 2017 |
1 |
| 137 |
28605057 | Synthesis and Biological Evaluation of New Diarylpyrazole and Triarylimidazoline Derivatives as Selective COX-2 Inhibitors. | 2017 Aug |
2 |
| 138 |
28626213 | The Efficacy of Imrecoxib and Celecoxib in Axial Spondyloarthritis and Their Influence on Serum Dickopff-Related Protein 1 (DKK-1) Levels. | 2017 Jun 19 |
1 |
| 139 |
28650862 | The potential combinational effect of miR-34a with celecoxib in osteosarcoma. | 2017 Sep |
2 |
| 140 |
28668885 | Interactive Analysis of TX-1123 with Cyclo-oxygenase: Design of COX2 Selective TX Analogs. | 2017 Jul |
2 |
| 141 |
28676124 | Evaluation of rational nonsteroidal anti-inflammatory drugs and gastro-protective agents use; association rule data mining using outpatient prescription patterns. | 2017 Jul 4 |
1 |
| 142 |
28851389 | Immunohistochemical staining with non-phospho β-catenin as a diagnostic and prognostic tool of COX-2 inhibitor therapy for patients with extra-peritoneal desmoid-type fibromatosis. | 2017 Aug 29 |
1 |
| 143 |
28881160 | Effective treatment of aggressive fibromatosis with celecoxib guided by genetic testing. | 2017 Oct 3 |
1 |
| 144 |
28929561 | One-Pot, Three-Component Sulfonimidamide Synthesis Exploiting the Sulfinylamine Reagent N-Sulfinyltritylamine, TrNSO. | 2017 Nov 20 |
1 |
| 145 |
29024866 | Diclofenac but not celecoxib improves endothelial function in rheumatoid arthritis: A study in adjuvant-induced arthritis. | 2017 Nov |
1 |
| 146 |
29031075 | Discovery of new indomethacin-based analogs with potentially selective cyclooxygenase-2 inhibition and observed diminishing to PGE2 activities. | 2017 Dec 1 |
1 |
| 147 |
29066864 | Variability of the drug response to nonsteroidal anti-inflammatory drugs according to cyclooxygenase-2 genetic polymorphism. | 2017 |
6 |
| 148 |
29152087 | Specific role of RhoC in tumor invasion and metastasis. | 2017 Oct 20 |
1 |
| 149 |
29199735 | Ligand-free, palladacycle-facilitated Suzuki coupling of hindered 2-arylbenzothiazole derivatives yields potent and selective COX-2 inhibitors. | 2017 Dec 19 |
1 |
| 150 |
29250535 | HPV16 E6 Promotes Breast Cancer Proliferation via Upregulation of COX-2 Expression. | 2017 |
1 |